Absolute Antibody/Kerafast
Absolute Antibody and Kerafast are committed to improving the selection of research tools available to the global scientific community. The companies merged in 2018 to increase access to unique reagents and technology, including recombinant antibodies in engineered formats, custom antibody services and novel biomaterials from academic labs.